I am optimistic we should see similar results..
first 12 people were severe cases after all other treatments had failed.. basically, this was their last resort.
this time its “moderate/severe” patients, treated within 72hours of being placed on ventilation. So I believe that a lesser % of patients n the 300 person study, are going to have conditions as dire as the first 12.
happy to be corrected on this.
Cell Therapy News/Articles, page-2973
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.76 |
Change
0.230(15.1%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.78 | $1.71 | $8.392M | 4.813M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 67323 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 1025 | 1 |
View Market Depth
| Last trade - 10.41am 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |